Skip to content
Latest News
SCYNEXIS Stock Soared 92% on $593M GSK License Agreement

The SCYNEXIS Inc (NASDAQ: SCYX) stock price soared 91.6% after signing an exclusive agreement with GSK to commercialise and further develop Brexafemme (ibrexafungerp tablets), an FDA-approved treatment for vulvovaginal candid

Simon Mugo
Why Scotgold Resources Shares Rose 15% Despite H1 ’23 Losses

The Scotgold Resources Ltd (LON: SGZ) share price rose 15.2% after releasing its financial results for the six months to 31 December 2022. The Scottish gold producer revealed that it produced 3,809 ounces of gold during the s

Simon Mugo
Genedrive Shares Fell 11.2% Despite NICE Final Recommendation

The Genedrive PLC (LON: GDR) share price fell 11.2% after revealing that the UK’s National Institute for Health and Care Excellence (NICE) has ratified and finalised its recommendation after a public consultation process.

Simon Mugo
Why Royal Mail (IDS) Shares Remain Muted on CWU Strike Threats

The Royal Mail share price, now known as International Distributions Services PLC (LON: IDS), inched higher today despite the Communication Workers Union (CWU) saying that it would call for further strikes soon if it cannot r

Simon Mugo
GBPUSD Fell As Dollar Gained on Pound, Risk Sentiment Abates

The GBPUSD currency pair was trading down over 29 pips as the US dollar rallied against the Sterling pound as investor risk appetite abated slightly. The currency pair is still on track to reaching its January 2023 and Decemb

Simon Mugo
AbbVie Stock Has Risen 10.4% From Its Feb Lows. Is There More?

The AbbVie Inc (NYSE: ABBV) stock price has risen 10.4% from its February lows but is still down 2.23% for the year after falling heavily in January. The recent rally in AbbVie stock has left many wondering whether there coul

Simon Mugo
Futura Medical (FUM) Shares Surged 9.53% on ED Drug Progress

The Futura Medical plc. (LON: FUM) share price surged 9.53% after revealing that it had submitted all the confirmatory data requested by the US Food and Drug Administration (FDA) concerning approving its MED3000 erectile dysf

Simon Mugo
AFC Energy Shares Rallied 5.7% on S+ Series, £2M ABB Funding

The AFC Energy plc (LON: AFC) share price rallied 5.68% after receiving a £2.0 million follow-on investment from ABB E-mobility as part of a partnership between the two firms that started in November 2021. The investment was

Simon Mugo
USDJPY Falls As the Japanese Yen Rallied on 2.2 Trillion Stimulus

The USDJPY currency pair was trading down over 50 pips as the US dollar remained weaker than the Japanese yen. The positive sentiment towards the yen was not dampened by the Bank of Japan’s Governor Haruhiko Kuroda’s statemen

Simon Mugo
Disney Stock Is Up 6.96% in 2023 Amid Job Cuts. What’s Next?

The Walt Disney Co (NYSE: DIS) stock price has risen 6.96% this year despite announcing plans to eliminate 7,000 roles in a bid to reduce its operating costs by up to $5.5 billion. The company has already started notifying th

Simon Mugo
Pinterest Stock Has Risen 11.3% YTD As It Cuts Staff and Space

The Pinterest Inc (NYSE: PINS) stock price has risen 11.3% this year amid layoffs as it looks to restructure its business to become a smaller, nimbler tech company as advertising revenues fall due to the challenging operating

Simon Mugo
Pennpetro Energy (PPP) Shares Dropped 36% on Multiple Releases

The Pennpetro Energy PLC (LON: PPP) share price dropped 36.2% after making four significant announcements. First, the company revealed that it had raised £1,545,759 via a share placement and subscription. The firm issued ten

Simon Mugo
Halma Shares Edged Higher on FirePro Acquisition – Here’s Why

The Halma plc (LON: HLMA) share price edged 2.04% higher after revealing that it had acquired FirePro, a leading designer and manufacturer of aerosol-based fire suppression systems, for €150 million (approx. £132 million) in

Simon Mugo
Why Nanoco Shares Were Trading Flat After Its Half-Year Results

The Nanoco Group PLC (LON: NANO) share price was trading flat after releasing its interim financial results for the half year ending 31 January 2023. The company reported a 45% increase in revenues from £1.1 million in the pr

Simon Mugo
Skinbiotherapeutics (SBTX) Shares Plunged 24% on H1’23 Results

The Skinbiotherapeutics PLC (LON: SBTX) share price plunged 23.9% after releasing its financial results for the six months to 31 December 2022 (H1 2023). The company generated revenues worth £77,000 during the review period,

Simon Mugo
GBPUSD Rises on Positive Investor Sentiment As the Dollar Falls

The GBPUSD currency pair was trading up over 50 pips, boosted by positive investor sentiment after Silicon Valley Bank found a buyer in First Citizens Bank & Trust Company. The buyout of SVB boosted risk assets such as th

Simon Mugo
Palantir’ Stock Price Is at Risk As Government Contract Wins Slow

The Palantir Technologies Inc (NYSE: PLTR) stock price faces a significant threat in the form of dwindling government contracts as privacy concerns mount. The company is already losing contracts in Europe after Germany’s Fede

Simon Mugo
First Republic Bank (FRC) Stock Rallied 26.2% on Fed Loan Hopes

The First Republic Bank (NYSE: FRC) stock price rallied 26.2%, hoping the Federal Reserve may consider lending it a helping hand by expanding its emergency funding program. The Fed could expand its Bank Term Funding Program (

Simon Mugo
ImmuPharma (IMM) Shares Surged 26% on Lupuzor FDA Progress

The ImmuPharma PLC (LON: IMM) share price surged 26.2% after issuing a further update about its Lupuzor™ (P140) program in patients with systemic lupus erythematosus (SLE). The company noted that it had submitted a phase 2/3

Simon Mugo
Why Avacta Shares Barely Moved on the Data Poster Presentation

The  Avacta Group Plc (LON: AVCT) share price barely moved after announcing that it would present a poster entitled 'AVA3996, a novel pre|CISION™ medicine, targeted to the tumor microenvironment via Fibroblast Activation

Simon Mugo
Analysis Stocks Markets Strategies